Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells

Purevdorj B. Olkhanud, Bazarragchaa Damdinsuren, Monica Bodogai, Ronald E. Gress, Ranjan Sen, Katarzyna Wejksza, Enkhzol Malchinkhuu, Robert P. Wersto, Arya Biragyn

Research output: Contribution to journalArticle

Abstract

Pulmonary metastasis of breast cancer requires recruitment and expansion of T-regulatory cells (Treg) that promote escape from host protective immune cells. However, it remains unclear precisely how tumors recruit Tregs to support metastatic growth. Here we report the mechanistic involvement of a unique and previously undescribed subset of regulatory B cells. These cells, designated tumor-evoked Bregs (tBreg), phenotypically resemble activated but poorly proliferative mature B2 cells (CD19+ CD25High CD69 High) that express constitutively active Stat3 and B7-H1 High CD81High CD86High CD62LLow IgMInt. Our studies with the mouse 4T1 model of breast cancer indicate that the primary role of tBregs in lung metastases is to induce TGF-β-dependent conversion of FoxP3+ Tregs from resting CD4 + T cells. In the absence of tBregs, 4T1 tumors cannot metastasize into the lungs efficiently due to poor Treg conversion. Our findings have important clinical implications, as they suggest that tBregs must be controlled to interrupt the initiation of a key cancer-induced immunosuppressive event that is critical to support cancer metastasis.

Original languageEnglish (US)
Pages (from-to)3505-3515
Number of pages11
JournalCancer Research
Volume71
Issue number10
DOIs
StatePublished - May 15 2011
Externally publishedYes

Fingerprint

Regulatory B-Lymphocytes
Regulatory T-Lymphocytes
Breast Neoplasms
Neoplasm Metastasis
T-Lymphocytes
Neoplasms
Lung
Immunosuppressive Agents
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Olkhanud, P. B., Damdinsuren, B., Bodogai, M., Gress, R. E., Sen, R., Wejksza, K., ... Biragyn, A. (2011). Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. Cancer Research, 71(10), 3505-3515. https://doi.org/10.1158/0008-5472.CAN-10-4316

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. / Olkhanud, Purevdorj B.; Damdinsuren, Bazarragchaa; Bodogai, Monica; Gress, Ronald E.; Sen, Ranjan; Wejksza, Katarzyna; Malchinkhuu, Enkhzol; Wersto, Robert P.; Biragyn, Arya.

In: Cancer Research, Vol. 71, No. 10, 15.05.2011, p. 3505-3515.

Research output: Contribution to journalArticle

Olkhanud, PB, Damdinsuren, B, Bodogai, M, Gress, RE, Sen, R, Wejksza, K, Malchinkhuu, E, Wersto, RP & Biragyn, A 2011, 'Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells', Cancer Research, vol. 71, no. 10, pp. 3505-3515. https://doi.org/10.1158/0008-5472.CAN-10-4316
Olkhanud, Purevdorj B. ; Damdinsuren, Bazarragchaa ; Bodogai, Monica ; Gress, Ronald E. ; Sen, Ranjan ; Wejksza, Katarzyna ; Malchinkhuu, Enkhzol ; Wersto, Robert P. ; Biragyn, Arya. / Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. In: Cancer Research. 2011 ; Vol. 71, No. 10. pp. 3505-3515.
@article{8c62a6fe0a424669898ca906071fdae3,
title = "Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells",
abstract = "Pulmonary metastasis of breast cancer requires recruitment and expansion of T-regulatory cells (Treg) that promote escape from host protective immune cells. However, it remains unclear precisely how tumors recruit Tregs to support metastatic growth. Here we report the mechanistic involvement of a unique and previously undescribed subset of regulatory B cells. These cells, designated tumor-evoked Bregs (tBreg), phenotypically resemble activated but poorly proliferative mature B2 cells (CD19+ CD25High CD69 High) that express constitutively active Stat3 and B7-H1 High CD81High CD86High CD62LLow IgMInt. Our studies with the mouse 4T1 model of breast cancer indicate that the primary role of tBregs in lung metastases is to induce TGF-β-dependent conversion of FoxP3+ Tregs from resting CD4 + T cells. In the absence of tBregs, 4T1 tumors cannot metastasize into the lungs efficiently due to poor Treg conversion. Our findings have important clinical implications, as they suggest that tBregs must be controlled to interrupt the initiation of a key cancer-induced immunosuppressive event that is critical to support cancer metastasis.",
author = "Olkhanud, {Purevdorj B.} and Bazarragchaa Damdinsuren and Monica Bodogai and Gress, {Ronald E.} and Ranjan Sen and Katarzyna Wejksza and Enkhzol Malchinkhuu and Wersto, {Robert P.} and Arya Biragyn",
year = "2011",
month = "5",
day = "15",
doi = "10.1158/0008-5472.CAN-10-4316",
language = "English (US)",
volume = "71",
pages = "3505--3515",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells

AU - Olkhanud, Purevdorj B.

AU - Damdinsuren, Bazarragchaa

AU - Bodogai, Monica

AU - Gress, Ronald E.

AU - Sen, Ranjan

AU - Wejksza, Katarzyna

AU - Malchinkhuu, Enkhzol

AU - Wersto, Robert P.

AU - Biragyn, Arya

PY - 2011/5/15

Y1 - 2011/5/15

N2 - Pulmonary metastasis of breast cancer requires recruitment and expansion of T-regulatory cells (Treg) that promote escape from host protective immune cells. However, it remains unclear precisely how tumors recruit Tregs to support metastatic growth. Here we report the mechanistic involvement of a unique and previously undescribed subset of regulatory B cells. These cells, designated tumor-evoked Bregs (tBreg), phenotypically resemble activated but poorly proliferative mature B2 cells (CD19+ CD25High CD69 High) that express constitutively active Stat3 and B7-H1 High CD81High CD86High CD62LLow IgMInt. Our studies with the mouse 4T1 model of breast cancer indicate that the primary role of tBregs in lung metastases is to induce TGF-β-dependent conversion of FoxP3+ Tregs from resting CD4 + T cells. In the absence of tBregs, 4T1 tumors cannot metastasize into the lungs efficiently due to poor Treg conversion. Our findings have important clinical implications, as they suggest that tBregs must be controlled to interrupt the initiation of a key cancer-induced immunosuppressive event that is critical to support cancer metastasis.

AB - Pulmonary metastasis of breast cancer requires recruitment and expansion of T-regulatory cells (Treg) that promote escape from host protective immune cells. However, it remains unclear precisely how tumors recruit Tregs to support metastatic growth. Here we report the mechanistic involvement of a unique and previously undescribed subset of regulatory B cells. These cells, designated tumor-evoked Bregs (tBreg), phenotypically resemble activated but poorly proliferative mature B2 cells (CD19+ CD25High CD69 High) that express constitutively active Stat3 and B7-H1 High CD81High CD86High CD62LLow IgMInt. Our studies with the mouse 4T1 model of breast cancer indicate that the primary role of tBregs in lung metastases is to induce TGF-β-dependent conversion of FoxP3+ Tregs from resting CD4 + T cells. In the absence of tBregs, 4T1 tumors cannot metastasize into the lungs efficiently due to poor Treg conversion. Our findings have important clinical implications, as they suggest that tBregs must be controlled to interrupt the initiation of a key cancer-induced immunosuppressive event that is critical to support cancer metastasis.

UR - http://www.scopus.com/inward/record.url?scp=79956131523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956131523&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-4316

DO - 10.1158/0008-5472.CAN-10-4316

M3 - Article

C2 - 21444674

AN - SCOPUS:79956131523

VL - 71

SP - 3505

EP - 3515

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 10

ER -